Bardia Nourbakhsh

2.6k total citations
58 papers, 1.5k citations indexed

About

Bardia Nourbakhsh is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Bardia Nourbakhsh has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pathology and Forensic Medicine, 14 papers in Psychiatry and Mental health and 11 papers in Neurology. Recurrent topics in Bardia Nourbakhsh's work include Multiple Sclerosis Research Studies (42 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers) and Peripheral Neuropathies and Disorders (6 papers). Bardia Nourbakhsh is often cited by papers focused on Multiple Sclerosis Research Studies (42 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers) and Peripheral Neuropathies and Disorders (6 papers). Bardia Nourbakhsh collaborates with scholars based in United States, Iran and Italy. Bardia Nourbakhsh's co-authors include Emmanuelle Waubant, Jennifer Graves, Ellen M. Mowry, Hongmei Li, Abdolmohamad Rostami, Farinaz Safavi, Amir Reza Azimi, Elizabeth Crabtree‐Hartman, Daniel Pelletier and Laura Julián and has published in prestigious journals such as The Journal of Immunology, Neurology and PEDIATRICS.

In The Last Decade

Bardia Nourbakhsh

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bardia Nourbakhsh United States 18 877 357 324 268 208 58 1.5k
Jessica Frau Italy 25 1.1k 1.2× 354 1.0× 353 1.1× 317 1.2× 255 1.2× 111 1.8k
Peer Baneke United States 4 1.1k 1.2× 251 0.7× 201 0.6× 268 1.0× 161 0.8× 6 1.6k
Lindsay Rechtman United States 9 1.0k 1.1× 373 1.0× 192 0.6× 302 1.1× 137 0.7× 13 1.7k
Giuseppe Fenu Italy 23 1.0k 1.2× 341 1.0× 196 0.6× 213 0.8× 226 1.1× 92 1.5k
Anne Helme United States 4 1.0k 1.2× 225 0.6× 194 0.6× 263 1.0× 143 0.7× 10 1.5k
Nick Rijke United States 4 1.0k 1.2× 227 0.6× 195 0.6× 259 1.0× 144 0.7× 5 1.5k
Merja Soilu‐Hänninen Finland 27 1.2k 1.4× 372 1.0× 600 1.9× 345 1.3× 339 1.6× 72 2.2k
Robert Hoepner Switzerland 19 543 0.6× 324 0.9× 169 0.5× 178 0.7× 292 1.4× 96 1.1k
Clare Walton United Kingdom 4 976 1.1× 214 0.6× 192 0.6× 260 1.0× 135 0.6× 8 1.5k
Jonathan B. Strober United States 24 820 0.9× 677 1.9× 207 0.6× 444 1.7× 111 0.5× 43 1.9k

Countries citing papers authored by Bardia Nourbakhsh

Since Specialization
Citations

This map shows the geographic impact of Bardia Nourbakhsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bardia Nourbakhsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bardia Nourbakhsh more than expected).

Fields of papers citing papers by Bardia Nourbakhsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bardia Nourbakhsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bardia Nourbakhsh. The network helps show where Bardia Nourbakhsh may publish in the future.

Co-authorship network of co-authors of Bardia Nourbakhsh

This figure shows the co-authorship network connecting the top 25 collaborators of Bardia Nourbakhsh. A scholar is included among the top collaborators of Bardia Nourbakhsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bardia Nourbakhsh. Bardia Nourbakhsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cordano, Christian, Emmanuelle Waubant, & Bardia Nourbakhsh. (2024). The observation of seasonal variation of fatigue in multiple sclerosis depends on the measurement instrument. Multiple Sclerosis and Related Disorders. 94. 106252–106252. 1 indexed citations
2.
Kalaitzidis, Grigorios, Olwen C. Murphy, Angeliki Filippatou, et al.. (2024). Homonymous hemi-macular atrophy in multiple sclerosis. Multiple Sclerosis Journal. 30(14). 1802–1814.
3.
Nourbakhsh, Bardia, et al.. (2023). Serum Sickness/Serum Sickness–like Reactions Following Ocrelizumab Infusion in 2 Patients With Multiple Sclerosis. International Journal of MS Care. 25(5). 196–198. 1 indexed citations
4.
Nourbakhsh, Bardia, Pavan Bhargava, Sonam Dilwali, et al.. (2023). Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis. Multiple Sclerosis Journal. 29(8). 936–944. 5 indexed citations
5.
Fitzgerald, Kathryn C., Matthew D. Smith, Sol Kim, et al.. (2021). Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism. Cell Reports Medicine. 2(10). 100424–100424. 50 indexed citations
6.
Krysko, Kristen M., Antje Bischof, Bardia Nourbakhsh, et al.. (2021). A pilot study of oxidative pathways in MS fatigue: randomized trial of N‐acetyl cysteine. Annals of Clinical and Translational Neurology. 8(4). 811–824. 11 indexed citations
7.
Nourbakhsh, Bardia, Emmanuelle Waubant, Andrea W.M. Evers, & Andrew Solomon. (2021). Ethical considerations in the treatment of multiple sclerosis fatigue. Multiple Sclerosis and Related Disorders. 54. 103129–103129. 7 indexed citations
8.
Fitzgerald, Kathryn C., et al.. (2020). Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue. Multiple Sclerosis Journal. 27(6). 942–953. 11 indexed citations
9.
Akhbardeh, Alireza, et al.. (2020). Novel MS vital sign: multi‐sensor captures upper and lower limb dysfunction. Annals of Clinical and Translational Neurology. 7(3). 288–295. 8 indexed citations
10.
Krysko, Kristen M., Alireza Akhbardeh, Bardia Nourbakhsh, et al.. (2020). Biosensor vital sign detects multiple sclerosis progression. Annals of Clinical and Translational Neurology. 8(1). 4–14. 7 indexed citations
11.
Safavi, Farinaz, Bardia Nourbakhsh, & Amir Reza Azimi. (2020). B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran. Multiple Sclerosis and Related Disorders. 43. 102195–102195. 107 indexed citations
12.
Krysko, Kristen M., Antje Bischof, Bardia Nourbakhsh, et al.. (2019). N-acetyl cysteine for fatigue in progressive multiple sclerosis: A pilot randomized double-blind placebo-controlled trial (P5.2-093). Neurology. 92(15_supplement). 3 indexed citations
13.
14.
Kühle, Jens, Bardia Nourbakhsh, Donna Grant, et al.. (2017). Serum neurofilament is associated with progression of brain atrophy and disability in early MS. Neurology. 88(9). 826–831. 164 indexed citations
15.
Block, Valerie J., Antoine Lizée, Elizabeth Crabtree‐Hartman, et al.. (2017). Continuous Daily Assessment Of Multiple Sclerosis Disability Using Remote Step Count Monitoring (P1.376). Neurology. 88(16_supplement). 1 indexed citations
16.
Graves, Jennifer, Tanuja Chitnis, Bianca Weinstock‐Guttman, et al.. (2016). Maternal Illness in Pregnancy and Perinatal Exposure to Pesticides Are Associated with Risk for Pediatric Onset MS (S29.005). Neurology. 86(16_supplement). 1 indexed citations
17.
Nourbakhsh, Bardia, Sharmilee Gnanapavan, Gavin Giovannoni, et al.. (2016). Association of Serum Neurofilament Light Chain with Cognitive and Disability Measures in Patients with Very Early MS: A Longitudinal Study (P1.396). Neurology. 86(16_supplement). 1 indexed citations
18.
Waubant, Emmanuelle, et al.. (2016). Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment. JAMA Neurology. 73(7). 790–790. 151 indexed citations
19.
Nourbakhsh, Bardia, Amir‐Hadi Maghzi, Laura Julián, et al.. (2015). Longitudinal associations between MRI and cognitive changes in very early MS. Multiple Sclerosis and Related Disorders. 5. 47–52. 22 indexed citations
20.
Li, Hongmei, Patricia Gonnella, Farinaz Safavi, et al.. (2012). Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 254(1-2). 28–38. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Frau Breakdown of academic impact, for papers by Peer Baneke Breakdown of academic impact, for papers by Lindsay Rechtman Breakdown of academic impact, for papers by Giuseppe Fenu Breakdown of academic impact, for papers by Anne Helme Breakdown of academic impact, for papers by Nick Rijke Breakdown of academic impact, for papers by Merja Soilu‐Hänninen Breakdown of academic impact, for papers by Robert Hoepner Breakdown of academic impact, for papers by Clare Walton Breakdown of academic impact, for papers by Jonathan B. Strober
Rankless by CCL
2026